Zimmer Partners, LP Allogene Therapeutics, Inc. Transaction History
Zimmer Partners, LP
- $4.52 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding ALLO
# of Institutions
174Shares Held
156MCall Options Held
202KPut Options Held
76.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$20.4 Million0.84% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$17.9 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA12.3MShares$13.4 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR11.1MShares$12.1 Million5.97% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.4MShares$11.4 Million1.06% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $157M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...